Company News

Beiersdorf Takes Majority Stake in Skin Microbiome Company S-Biomedic NV

Life sciences company is an “ideal strategic fit," according to Beiersdorf SVP of R&D Dr. Gitta Neufang.

Author Image

By: Christine Esposito

Editor-in-Chief

Beiersdorf AG has acquired a majority stake in S-Biomedic NV, a Belgium-based life-science company focused on skin microbiome research. Beiersdorf had earlier invested in S-Biomedic in 2018 as part of its corporate venture capital activities. A purchase price was not disclosed. S-Biomedic will continue to be managed as a standalone entity under Beiersdorf’s existing microbiome program and will complement the company’s own research activities in this field. The company was founded by Ver...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters